A.I. BASED MEDICINE
Dr Robert Hess takes a look at new data on the protein-based inactivated vaccine.
Many people who are skeptical of mRNA technology have been waiting for a conventional vaccine against co...
The Delta variant of coronavirus does not appear to lead to a more severe course of disease in children than earlier forms of the virus, such as the Alpha or Beta variants. This finding emerged ...
Merck Sharp and Dohme (MSD), the US pharmaceutical giant based in Kenilworth, New York, last week reported positive results from a Phase III trial of its new corona drug, molnupiravir. The manuf...
The issue of booster vaccination has risen high on the agenda, and every country is taking a different approach to it. Israel, Austria and Russia are already offering booster jabs to the general...
As experts in the field of human and molecular genetics and thus also on the topic of mutations, Dr Robert Hess provides regular updates and forecasts of where the pandemic might be heading. Rec...
CureVac's first-generation vaccine candidate CVnCoV unfortunately fell by the wayside in mid-June after failing to meet the statistical criteria for success, but there is now news regarding a mo...
Doctor Robert Hess comments about recent studies that have established a strong link between the presence of autoantibodies against interferon-I and a severe progression of disease after infecti...
For the first time since the Salvagene SARS-CoV-2 Task Force was established 18 months ago, a difference of opinion has arisen, specifically with regard to the Lambda variant. What everyone agre...
...which makes it all the more difficult to make any firm predictions for the autumn.
In focus: Vaccine side-effects versus post-acute sequelae (“Long Covid”).
Dr Robert Hess skepticism regarding the efficacy of all previous vaccines against the Delta variant has been confirmed by the announcement from BioNTech/Pfizer that they are working on a vaccine...